TLS data
 

BioCommunique

Corporate Newsletter

 
 
HearTake in important insights from Intuitive Surgical CEO Gary Guthart, Reva Medical CEO Reggie Groves and the executive chairman of the Alfred E. Mann Founda

Industry-Leading Medical Technology Conference DeviceTalks Returns to California

  • Fri Nov 09 20:20:00 GMT 2018
  • California
  • Author DeviceTalks West

DeviceTalks, a conference series designed for the medical technology industry, returns to California on Dec. 11th-12th in Costa Mesa. Biocom members can save 20% with code “DEVICEFEST”.
 
This year’s DeviceTalks West event features exclusive insights from Intuitive Surgical CEO Gary Guthart, Reva Medical CEO Reggie Groves and the executive chairman of the Alfred E. Mann Foundation, Dr. Robert Greenberg.
 
The two-day conference also features panels centered around the latest innovations in diabetes technology, robotics and cybersecurity. DeviceTalks West speakers will explore regulatory and investment trends, as well as the state of research and development among major medtech companies.
 
DeviceTalks West also includes hours of networking opportunities, giving attendees the chance to mingle with the medtech industry’s brightest minds.
 
“We are excited to return to California for our annual DeviceTalks West event. Attendees can expect to learn from an all-star lineup of speakers, gaining insight into the rapidly-evolving medtech industry,” said Sarah Faulkner, content manager for DeviceTalks. “We’re also delighted to host the LEAP Awards at DeviceTalks West, where we will honor the most innovative products serving the design engineering space.”
 
Don’t miss out on this exciting event - visit west.devicetalks.com to check out the event’s two-day agenda and register today!
 

 
 

Stay in the know with the Biocommunique

Sign up for Biocom's bi-weekly newsletter to get all the latest life science news sent directly to your inbox.

 
 

Related Articles View All

https://www.biocom.org/servlet/servlet.ImageServer?id=0155A00000A2anWQAR&oid=00DA0000000Kz7JMAS  
Apply now for UC San Diego's new program which gives fellows experiences in sharing the university's health science news with the public.
https://www.biocom.org/servlet/servlet.ImageServer?id=0155A00000A2an2QAB&oid=00DA0000000Kz7JMAS  
Hear from Eric Topol, MD and Abraham Verghese, MD on latest trends in AI in medicine, rare disease, oncology and more.
https://www.biocom.org/servlet/servlet.ImageServer?id=0155A00000A2KtKQAV&oid=00DA0000000Kz7JMAS  
Genentech, a subsidiary of Roche, took a dive into the $20 billion NASH market with the acquisition of San Diego-based Biocom member, Jecure Therapeutics, a company with a portfolio of preclinical NLRP3 inhibitors aimed at serious inflammatory diseases.
https://www.biocom.org/servlet/servlet.ImageServer?id=0155A00000A2EyUQAV&oid=00DA0000000Kz7JMAS  
Ferring accesses Evotec's integrated small molecule discovery and development platform to progress new molecules from concept to potential drug candidates.